HEADER HYDROLASE/HYDROLASE INHIBITOR 20-AUG-98 1BQY
TITLE PLASMINOGEN ACTIVATOR (TSV-PA) FROM SNAKE VENOM
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: TSV-PA;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: VIRIDOVIPERA STEJNEGERI;
SOURCE 3 ORGANISM_COMMON: STEJNEGER'S PIT VIPER;
SOURCE 4 ORGANISM_TAXID: 39682;
SOURCE 5 ORGAN: VENOM GLAND;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET
KEYWDS FIBRINOLYSIS, PLASMINOGEN ACTIVATOR, SERINE PROTEINASE, SNAKE VENOM,
KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX, BLOOD CLOTTING
EXPDTA X-RAY DIFFRACTION
AUTHOR M.A.A.PARRY,W.BODE
REVDAT 6 30-OCT-24 1BQY 1 REMARK
REVDAT 5 09-AUG-23 1BQY 1 REMARK LINK
REVDAT 4 13-JUL-11 1BQY 1 VERSN
REVDAT 3 24-FEB-09 1BQY 1 VERSN
REVDAT 2 08-DEC-99 1BQY 3 HETATM
REVDAT 1 20-AUG-99 1BQY 0
JRNL AUTH M.A.PARRY,U.JACOB,R.HUBER,A.WISNER,C.BON,W.BODE
JRNL TITL THE CRYSTAL STRUCTURE OF THE NOVEL SNAKE VENOM PLASMINOGEN
JRNL TITL 2 ACTIVATOR TSV-PA: A PROTOTYPE STRUCTURE FOR SNAKE VENOM
JRNL TITL 3 SERINE PROTEINASES.
JRNL REF STRUCTURE V. 6 1195 1998
JRNL REFN ISSN 0969-2126
JRNL PMID 9753698
JRNL DOI 10.1016/S0969-2126(98)00119-1
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.8
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7
REMARK 3 NUMBER OF REFLECTIONS : 17215
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.178
REMARK 3 FREE R VALUE : 0.258
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 861
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3594
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 50
REMARK 3 SOLVENT ATOMS : 162
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.870
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : RESTRAINTS
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 PARAMETER FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1BQY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000172014.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : APR-97
REMARK 200 TEMPERATURE (KELVIN) : 293.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : NULL
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : CU FILTER
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA)
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17988
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7
REMARK 200 DATA REDUNDANCY : 2.000
REMARK 200 R MERGE (I) : 0.10200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59
REMARK 200 COMPLETENESS FOR SHELL (%) : 82.1
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.44400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: X-PLOR 3.8
REMARK 200 STARTING MODEL: PDB ENTRY 3PTB
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.64500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.83500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.71000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.83500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.64500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.71000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 45.29000
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -33.71000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 245.50500
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 LYS A 95 CD CE NZ
REMARK 480 LYS A 95A CG CD CE NZ
REMARK 480 GLU A 98 CG CD OE1 OE2
REMARK 480 LYS A 148 CD CE NZ
REMARK 480 GLU A 149 CD OE1 OE2
REMARK 480 GLN A 175 CG CD OE1 NE2
REMARK 480 HIS A 218 CG ND1 CD2 CE1 NE2
REMARK 480 LYS A 245A CD CE NZ
REMARK 480 LYS B 95 CD CE NZ
REMARK 480 LYS B 95A CG CD CE NZ
REMARK 480 GLU B 98 CG CD OE1 OE2
REMARK 480 LYS B 148 CG CD CE NZ
REMARK 480 ARG B 169 CZ NH1 NH2
REMARK 480 GLN B 175 CG CD OE1 NE2
REMARK 480 HIS B 218 CG ND1 CD2 CE1 NE2
REMARK 480 LYS B 245A CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 28 -4.06 -59.34
REMARK 500 HIS A 71 -82.57 -122.05
REMARK 500 ASP A 102 77.17 -68.41
REMARK 500 ALA A 119 147.97 -175.89
REMARK 500 GLU A 149 50.59 -90.95
REMARK 500 THR A 179 33.64 -85.34
REMARK 500 PHE A 193 3.90 84.14
REMARK 500 HIS B 27 42.79 -146.37
REMARK 500 LEU B 41 -58.48 -120.36
REMARK 500 HIS B 71 -86.27 -133.91
REMARK 500 TYR B 172 51.10 -112.03
REMARK 500 THR B 179 36.89 -86.95
REMARK 500 SER B 214 -66.22 -123.32
REMARK 500 LYS B 245A 6.75 -68.46
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS GLU-GLY-ARG-CMK-
REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO
REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL
REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57. RESIDUE GLU OF THE
REMARK 600 INHIBITOR IS MODELED WITH ZERO OCCUPANCY.
REMARK 615
REMARK 615 ZERO OCCUPANCY ATOM
REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 615 M RES C SSEQI
REMARK 615 0GJ A 1
REMARK 615 0GJ B 1
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)METHYL]
REMARK 630 AMINO}-1-[(1S)-2-CHLORO-1-HYDROXYETHYL]BUTYL}GLYCINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0GJ A 1
REMARK 630 0GJ B 1
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: GLU GLY AR7 0QE
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ A 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ B 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: A
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE IN CHAIN A
REMARK 800
REMARK 800 SITE_IDENTIFIER: B
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE IN CHAIN B
DBREF 1BQY A 16 245 PIR A57290 A57290 25 258
DBREF 1BQY B 16 245 PIR A57290 A57290 25 258
SEQRES 1 A 234 VAL PHE GLY GLY ASP GLU CYS ASN ILE ASN GLU HIS ARG
SEQRES 2 A 234 SER LEU VAL VAL LEU PHE ASN SER ASN GLY PHE LEU CYS
SEQRES 3 A 234 GLY GLY THR LEU ILE ASN GLN ASP TRP VAL VAL THR ALA
SEQRES 4 A 234 ALA HIS CYS ASP SER ASN ASN PHE GLN LEU LEU PHE GLY
SEQRES 5 A 234 VAL HIS SER LYS LYS ILE LEU ASN GLU ASP GLU GLN THR
SEQRES 6 A 234 ARG ASP PRO LYS GLU LYS PHE PHE CYS PRO ASN ARG LYS
SEQRES 7 A 234 LYS ASP ASP GLU VAL ASP LYS ASP ILE MET LEU ILE LYS
SEQRES 8 A 234 LEU ASP SER SER VAL SER ASN SER GLU HIS ILE ALA PRO
SEQRES 9 A 234 LEU SER LEU PRO SER SER PRO PRO SER VAL GLY SER VAL
SEQRES 10 A 234 CYS ARG ILE MET GLY TRP GLY LYS THR ILE PRO THR LYS
SEQRES 11 A 234 GLU ILE TYR PRO ASP VAL PRO HIS CYS ALA ASN ILE ASN
SEQRES 12 A 234 ILE LEU ASP HIS ALA VAL CYS ARG THR ALA TYR SER TRP
SEQRES 13 A 234 ARG GLN VAL ALA ASN THR THR LEU CYS ALA GLY ILE LEU
SEQRES 14 A 234 GLN GLY GLY ARG ASP THR CYS HIS PHE ASP SER GLY GLY
SEQRES 15 A 234 PRO LEU ILE CYS ASN GLY ILE PHE GLN GLY ILE VAL SER
SEQRES 16 A 234 TRP GLY GLY HIS PRO CYS GLY GLN PRO GLY GLU PRO GLY
SEQRES 17 A 234 VAL TYR THR LYS VAL PHE ASP TYR LEU ASP TRP ILE LYS
SEQRES 18 A 234 SER ILE ILE ALA GLY ASN LYS ASP ALA THR CYS PRO PRO
SEQRES 1 B 234 VAL PHE GLY GLY ASP GLU CYS ASN ILE ASN GLU HIS ARG
SEQRES 2 B 234 SER LEU VAL VAL LEU PHE ASN SER ASN GLY PHE LEU CYS
SEQRES 3 B 234 GLY GLY THR LEU ILE ASN GLN ASP TRP VAL VAL THR ALA
SEQRES 4 B 234 ALA HIS CYS ASP SER ASN ASN PHE GLN LEU LEU PHE GLY
SEQRES 5 B 234 VAL HIS SER LYS LYS ILE LEU ASN GLU ASP GLU GLN THR
SEQRES 6 B 234 ARG ASP PRO LYS GLU LYS PHE PHE CYS PRO ASN ARG LYS
SEQRES 7 B 234 LYS ASP ASP GLU VAL ASP LYS ASP ILE MET LEU ILE LYS
SEQRES 8 B 234 LEU ASP SER SER VAL SER ASN SER GLU HIS ILE ALA PRO
SEQRES 9 B 234 LEU SER LEU PRO SER SER PRO PRO SER VAL GLY SER VAL
SEQRES 10 B 234 CYS ARG ILE MET GLY TRP GLY LYS THR ILE PRO THR LYS
SEQRES 11 B 234 GLU ILE TYR PRO ASP VAL PRO HIS CYS ALA ASN ILE ASN
SEQRES 12 B 234 ILE LEU ASP HIS ALA VAL CYS ARG THR ALA TYR SER TRP
SEQRES 13 B 234 ARG GLN VAL ALA ASN THR THR LEU CYS ALA GLY ILE LEU
SEQRES 14 B 234 GLN GLY GLY ARG ASP THR CYS HIS PHE ASP SER GLY GLY
SEQRES 15 B 234 PRO LEU ILE CYS ASN GLY ILE PHE GLN GLY ILE VAL SER
SEQRES 16 B 234 TRP GLY GLY HIS PRO CYS GLY GLN PRO GLY GLU PRO GLY
SEQRES 17 B 234 VAL TYR THR LYS VAL PHE ASP TYR LEU ASP TRP ILE LYS
SEQRES 18 B 234 SER ILE ILE ALA GLY ASN LYS ASP ALA THR CYS PRO PRO
HET 0GJ A 1 25
HET 0GJ B 1 25
HETNAM 0GJ L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)
HETNAM 2 0GJ METHYL]AMINO}-1-[(1S)-2-CHLORO-1-
HETNAM 3 0GJ HYDROXYETHYL]BUTYL}GLYCINAMIDE
FORMUL 3 0GJ 2(C14 H28 CL N6 O5 1+)
FORMUL 5 HOH *162(H2 O)
HELIX 1 1 ALA A 56 CYS A 58 5 3
HELIX 2 2 HIS A 165 ALA A 171 1 7
HELIX 3 3 VAL A 231 ALA A 243 5 13
HELIX 4 4 ALA B 56 CYS B 58 5 3
HELIX 5 5 HIS B 165 ALA B 171 1 7
HELIX 6 6 VAL B 231 ALA B 243 5 13
SHEET 1 A 7 GLN A 81 ASP A 84 0
SHEET 2 A 7 GLN A 65 PHE A 68 -1 N PHE A 68 O GLN A 81
SHEET 3 A 7 LEU A 30 ASN A 35 -1 N PHE A 34 O GLN A 65
SHEET 4 A 7 GLY A 39 ASN A 48 -1 N GLY A 44 O VAL A 31
SHEET 5 A 7 TRP A 51 THR A 54 -1 N VAL A 53 O THR A 45
SHEET 6 A 7 MET A 104 LEU A 108 -1 N ILE A 106 O VAL A 52
SHEET 7 A 7 PRO A 85 PHE A 89 -1 N PHE A 89 O LEU A 105
SHEET 1 B 7 HIS A 156 ASN A 161 0
SHEET 2 B 7 VAL A 135 GLY A 140 -1 N GLY A 140 O HIS A 156
SHEET 3 B 7 PRO A 198 CYS A 201 -1 N ILE A 200 O ARG A 137
SHEET 4 B 7 ILE A 208 TRP A 215 -1 N GLY A 211 O LEU A 199
SHEET 5 B 7 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212
SHEET 6 B 7 THR A 180 GLY A 184 -1 N ALA A 183 O GLY A 226
SHEET 7 B 7 ASN A 161 LEU A 163 -1 N LEU A 163 O CYS A 182
SHEET 1 C 4 GLN B 81 ASP B 84 0
SHEET 2 C 4 GLN B 65 PHE B 68 -1 N PHE B 68 O GLN B 81
SHEET 3 C 4 LEU B 30 ASN B 35 -1 N PHE B 34 O GLN B 65
SHEET 4 C 4 GLY B 39 THR B 45 -1 N GLY B 44 O VAL B 31
SHEET 1 D 3 TRP B 51 THR B 54 0
SHEET 2 D 3 MET B 104 LEU B 108 -1 N ILE B 106 O VAL B 52
SHEET 3 D 3 PRO B 85 PHE B 89 -1 N PHE B 89 O LEU B 105
SHEET 1 E 6 VAL B 135 GLY B 140 0
SHEET 2 E 6 HIS B 156 LEU B 163 -1 N ILE B 160 O CYS B 136
SHEET 3 E 6 THR B 180 GLY B 184 -1 N GLY B 184 O ASN B 161
SHEET 4 E 6 GLY B 226 LYS B 230 -1 N TYR B 228 O LEU B 181
SHEET 5 E 6 ILE B 208 TRP B 215 -1 N TRP B 215 O VAL B 227
SHEET 6 E 6 PRO B 198 CYS B 201 -1 N CYS B 201 O ILE B 208
SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.03
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03
SSBOND 3 CYS A 91 CYS A 245E 1555 1555 2.02
SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.04
SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03
SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03
SSBOND 7 CYS B 22 CYS B 157 1555 1555 2.04
SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.03
SSBOND 9 CYS B 91 CYS B 245E 1555 1555 2.03
SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.04
SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.03
SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.04
LINK C3 0GJ A 1 NE2 HIS A 57 1555 1555 1.49
LINK C2 0GJ A 1 OG SER A 195 1555 1555 1.44
LINK C3 0GJ B 1 NE2 HIS B 57 1555 1555 1.49
LINK C2 0GJ B 1 OG SER B 195 1555 1555 1.42
CISPEP 1 HIS A 218 PRO A 219 0 0.02
CISPEP 2 HIS B 218 PRO B 219 0 -0.91
SITE 1 AC1 9 HIS A 57 ASP A 189 THR A 190 PHE A 193
SITE 2 AC1 9 SER A 195 SER A 214 GLY A 216 GLY A 217
SITE 3 AC1 9 CYS A 220
SITE 1 AC2 12 HIS B 57 ASP B 189 THR B 190 PHE B 193
SITE 2 AC2 12 ASP B 194 SER B 195 SER B 214 GLY B 216
SITE 3 AC2 12 GLY B 217 CYS B 220 HOH B 482 HOH B 634
SITE 1 A 3 HIS A 57 ASP A 102 SER A 195
SITE 1 B 3 HIS B 57 ASP B 102 SER B 195
CRYST1 45.290 67.420 163.670 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022080 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014832 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006110 0.00000